Buy 3SBio Up to $10 – Analyst Blog
Source: http://www.zacks.com/stock/news/18307/Buy+3SBio+Up+to+%2410+-+Analyst+BlogPosted on Wednesday, March 18th, 2009 | In Stocks to Watch
3SBio Inc. (SSRX) is a China-based biotech company focused on developing and marketing therapeutics for nephrology, oncology and cancer supportive care. The company’s flagship product EPIAO is the number 1 brand in China’s EPO [erythropoietin] market.
Its second lead product TPIAO has gained rapid physician acceptance for thrombocytopenia and is making a meaningful contribution to the company’s top line growth. Recent deal with US-based AMAG Pharmaceuticals Inc. (AMAG) will boost its expansion into IV Iron market.
We believe shares of 3SBio are undervalued and are attractive at current levels. We maintain a Buy rating with a price target of $10.
Read the full analyst report on “SSRX”
Read the full analyst report on “AMAG”
Zacks Investment Research
Last 5 posts by Zacks Market Commentaries
- Settlement in Xerox-ACS Merger - Analyst Blog - November 24th, 2009
- Citi Expects Strong Economic Growth - Analyst Blog - November 24th, 2009
- Downgrading Expedia to Neutral - Analyst Blog - November 24th, 2009
- Foot Locker Misses Expectations - Analyst Blog - November 24th, 2009
- Patni Exceeds Estimates - Analyst Blog - November 24th, 2009
3sbio Inc, AMAG Pharmaceuticals Inc.;, Blog, cancer, China, oncology and cancer;, Stocks to Watch, therapeutics for nephrology, thrombocytopenia, United States, USD, Zacks Market Commentaries
 About Zacks Market Commentaries (http://www.zacks.com/)
Zacks Market Commentaries |
No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.